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Objective: In cerebral regions affected by ischemia, intrinsic vascular autoregulation is often lost. 
Blood flow delivery depends upon cardiac function and may be influenced by neuro-endocrine 
mediated myocardial suppression. Our objective is to evaluate the relation between ejection fraction 
(EF) and transcranial doppler (TCD) peak systolic velocities (PSV) in patients with cerebral ischemic 
events.
Methods: We conducted a retrospective cohort study from an existing TCD registry. We evaluated 
patients admitted within 24 hours of onset of a focal neurological deficit who had an echocardiogram 
and TCD performed within 72 hours of admission. 
Results: We identified 58 patients from March to October 2003. Eighty-one percent (n=47) had 
a hospital discharge diagnosis of ischemic stroke and 18.9% (n=11) had a diagnosis of transient 
ischemic attack. Fourteen patients had systolic dysfunction (EF<50%). The mean PSV in patients 
with normal systolic function (EF>50%) compared to those with systolic dysfunction (EF<50%) was 
as follows: middle cerebral artery 62.0 + 28.6 cm/s vs. 51.0 + 23.3 cm/s, p=0.11; anterior cerebral 
artery 52.1 + 21.6 cm/s vs. 45.9 + 22.7 cm/s, p=0.28; internal carotid artery 56.5 + 20.1 cm/s vs. 
46.4 + 18.4 cm/s, p=0.04; ophthalmic artery 18.6 + 7.2 cm/s vs. 15.3 + 5.2 cm/s, p=0.11; vertebral 
artery 34.0 + 13.9 cm/s vs. 31.6 + 15.0 cm/s, p=0.44. 
Conclusion: Cerebral blood flow in the internal carotid artery territory appears to be higher in 
cerebral ischemia patients with preserved left ventricular contractility. Our study was unable to 
differentiate pre-existing cardiac dysfunction from neuro-endocrine mediated myocardial stunning. 
Future research is necessary to better understand heart-brain interactions in this setting and to 
further explore the underlying mechanisms and consequences of neuro-endocrine mediated cardiac 
dysfunction. [West J Emerg Med. 2011;12(2):227-232.]
INTRODUCTION
Cerebral ischemic events (CIE) are a leading cause of 
death and morbidity in the United States with limited 
treatment options in the acute setting.1-6 This type of central 
nervous system injury has been associated with hemodynamic 
perturbation secondary to myocardial injury and dysfunction 
but the mechanisms underlying this relationship are poorly 
understood.5-7 Cardiac dysfunction in cerebral ischemia 
patients may have significant contributions in the pathogenesis 
of this disease. Within the territory of tissue affected by the 
ischemic insult, intrinsic autoregulation of the vasculature is 
lost rendering cerebral blood flow directly dependent upon 
cardiac output and contractility.8,9 
The relationship between cerebral blood flow and cardiac 
contractility in the acute presentation of patients with acute 
cerebral ischemia has not been comprehensively evaluated. 
Our objective in this preliminary, retrospective study was 
to evaluate the relationship between left ventricular systolic Volume XII, no. 2  :  May 2011    228  Western Journal of Emergency Medicine
function and transcranial doppler (TCD) peak systolic 
velocities (PSV) in patients with CIEs defined either as an 
acute ischemic stroke (AIS) or transient ischemic attack (TIA). 
METHODS
The Institutional Review Board for human research 
approved the study protocol and procedures. We conducted a 
retrospective chart review of CIE patients identified by our 
institutions TCD registry. 10 We included patients based on the 
following criteria: adult patients admitted within 24 hours of 
onset of a focal neurological deficit, record of both an 
echocardiogram and TCD performed within 72 hours of 
admission, and a discharge diagnosis of an AIS or TIA. Our 
exclusion criteria included age less than 18 years old, the 
presence of cerebral hemorrhage on initial neuro-imaging, or 
defined imaging parameters on echocardiography which could 
confound results. Echocardiogram exclusion criteria included 
the inability to measure the cardiac ejection fraction (EF) or 
the presence of severe left-sided stenotic or regurgitant 
valvular lesions that could potentially alter cardiac output. 
Additionally, given that certain TCD vessel distributions 
are technically more difficult to measure, we established a 
quality control measure to exclude individual vessel 
distributions from analysis if PSV or pulsatility index (PI) 
measurements could not be acquired in greater than 50% of 
patients. PSV vessel distributions included the middle cerebral 
artery, anterior cerebral artery, posterior cerebral artery, 
internal carotid artery, ophthalmic artery and vertebral artery. 
We measured PIs only in the middle cerebral and vertebral 
artery territories. 
A senior resident investigator, under the supervision of 
senior faculty investigators, used a standardized method of 
data collection to extract demographic and clinical data onto a 
data collection form. Echocardiogram reports were read by 
staff cardiologists and reviewed for the measured EF and the 
presence of severe left-sided stenotic or regurgitant valvular 
lesions. We considered an EF below 50% abnormal.11 
TCD studies in the registry were read by one of the 
investigators, a staff neurologist certified in neurosonology, and 
extracted by the senior resident investigator in a supervised and 
standardized fashion from the electronic medical record. We 
reviewed PSVs in the following vessel distributions: middle 
cerebral artery, anterior cerebral artery, posterior cerebral 
artery, internal carotid artery, ophthalmic artery and vertebral 
artery. We reported one PSV for each territory of the cerebral 
vasculature. We calculated the mean PSV for each vessel 
territory by combining the left and right PSV values in all 
patients. We performed the calculation this way because the 
PSV reference range for left and right vessel territories is 
identical and prior literature has demonstrated PSV and PI 
responsiveness in both sides of the middle cerebral artery 
territory to cardiac augmentation in the setting of AIS. 12-14
Similarly, we measured the PI for each territory of the 
middle cerebral artery and vertebral artery, and calculated 
their means. We did not measure PIs in other vessel 
distributions.
Prior literature has documented PSV and PI to correlate 
with cerebral blood flow.14-20 For our primary analysis, we 
stratified patients into low (EF<50%) and normal (EF>50%) 
contractility groups and calculated the mean PSV for each 
group. We performed a comparison of means using an un-
paired t-test with statistical significance of the two-tailed P 
value being less than 0.05. 
We reported the other results as the mean, standard 
deviation and 95% confidence interval where indicated. We 
used Fisher’s Exact Test in sub-group analysis comparing 
demographical differences between groups. We indicated 
statistical significance by an alpha error <0.05. 
RESULTS
We identified 197 TCD studies during from March to 
October 2003. Of these studies, 127 were excluded for 
including neurosurgical patients (n=63), neurology patients 
with conditions other than CIEs (n=37), and other patient 
populations (n= 27). We identified 70 CIE patients with both 
TCD studies and echocardiograms performed during their 
hospitalization. However, we excluded 12 of these patients 
because the TCD and echocardiogram were not performed 
within the first 72 hours of admission, or because 
echocardiograms revealed severely stenotic or regurgitant 
left-sided valvular abnormalities. Thus, 58 patients fulfilled 
our inclusion and exclusion criteria and were included into the 
study cohort. 
In the identified 58 patients, 81.1% (n=47) had a hospital 
discharge diagnosis of AIS and 18.9% (n=11) had a diagnosis 
of TIA. Demographics of our patient population are 
summarized in (Table). Male patients made up 67.2% of 
patients. The mean age was 65.0 + 14.8. The most common 
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Table. Demographics of patient population.
Demographic Number Percentage
Male 39 67.2
Hypertension 30 51.7
Hyperlipidemia 15 25.9
Diabetes 15 25.9
Congestive heart failure 6 10.3
Coronary artery disease/myocardial 
infarction
7 12.1
Stroke/transient ischemic attack 6 10.3
Tobacco use 4 6.9
Atrial fibrillation 3 5.2
Respiratory disease 2 3.4
Hemodialysis/renal insufficiency 2 3.4
Seizure 1 1.7
Cancer 1 1.7Western Journal of Emergency Medicine   229  Volume XII, no. 2  :  May 2011
co-morbidities were hypertension (51.7%), diabetes (25.9%) 
and hyperlipidemia (25.9%). Within the cohort, 10.3% of 
patients previously had an AIS or TIA and 10.3% of patients 
had a prior history of congestive heart failure. The mean initial 
NIH stroke scale for identified patients was 10.77 + 7.29 (95% 
CI 7.54 to 14.00). The mean initial systolic blood pressure for 
patients was 168.7 mmHg + 37.2 (95% CI 157.6 mmHg to 
179.9 mmHg). The mean initial heart rate was 83.6 + 16.7 
(95% CI 78.4 to 88.7).
Of the total sample of patients, 24.1% (n=14) had evidence 
of systolic dysfunction with an EF below 50% on 
echocardiography, and the rest, 75.8% (n=44), had normal 
systolic function. Among patients with systolic dysfunction 
14.3% (n=2) had a hospital discharge diagnosis of TIA. In the 
group with normal cardiac function 20.4% (n=9) had a hospital 
discharge diagnosis of TIA (p=1.0, Fisher’s Exact Test).
For TCD quality control, we ensured an adequate amount 
of PSV and PI measurements for each vessel distribution. We 
found that all vessel distributions met our quality threshold 
except for PSV measurements in the posterior cerebral artery 
distribution. We were only able to obtain 50.0% (n=29) of 
those measurements and therefore excluded the posterior 
cerebral artery vessel distribution from analysis. We 
performed PSV measurements for the middle cerebral artery 
distribution in 91.4% of patients (n=53), the anterior cerebral 
artery in 86.2% (n=50), the internal carotid in 88.0% (n=51), 
the ophthalmic artery in 69.0% (n=40), and the vertebral 
artery in 96.6% (n=56). For PI measurements, 91.4% (n=53) 
had middle cerebral artery PI measurements, and 96.6% 
(n=56) had vertebral artery PI measurements. 
The mean PI in patients with normal systolic function (EF 
>50%) compared to those with systolic dysfunction (EF < 
50%) was as follows: middle cerebral artery 1.07 + 0.35 vs. 
1.19 + 0.41, p=0.23; vertebral artery 1.18 + 0.34 vs 1.21 + 
0.28, p=0.62. We did not measure PIs in any other vessel 
distributions. 
The mean PSV in patients with normal systolic function 
(EF >50%) compared to those with systolic dysfunction (EF 
< 50%) was as follows (Figure): middle cerebral artery 62.0 
+ 28.6 cm/s vs. 51.0 + 23.3 cm/s, p=0.11; anterior cerebral 
artery 52.1 + 21.6 cm/s vs. 45.9 + 22.7 cm/s, p=0.28; internal 
carotid artery 56.5 + 20.1 cm/s vs. 46.4 + 18.4 cm/s, p=0.04; 
ophthalmic artery 18.6 + 7.2 cm/s vs. 15.3 + 5.2 cm/s, p=0.11; 
vertebral artery 34.0 + 13.9 cm/s vs. 31.6 + 15.0 cm/s, p=0.44. 
DISCUSSION
A significant proportion (13-28%) of patients with 
cerebral ischemia may have impaired cardiac contractility 
either at baseline from existing congestive heart failure or as 
part of the pathogenesis of the disease.21-23 The latter 
pathogenic mechanisms include catecholamine induced 
stunning or direct neuro-inhibition secondary to the ischemic 
insult.24,25 Our data suggests that cerebral blood flow (based on 
mean TCD PSV) in the internal carotid artery vascular 
territory is higher in acute cerebral ischemia patients with 
preserved left ventricular contractility. Additionally, we 
observed a trend towards higher cerebral blood flow among 
patients with preserved cardiac contractility in the territories 
of the middle cerebral artery, anterior cerebral artery, 
ophthalmic artery and vertebral artery. These findings serve to 
strengthen the limited existing animal literature and human 
pilot studies evaluating the impact of cardiac function on 
cerebral blood flow. 
Nearly two decades ago Keller et al8 demonstrated in a 
primate model that cerebral blood flow in both ischemic and 
non-ischemic brain regions correlates with cardiac output. 
Figure. Mean peak systolic velocities (cm/s) in normal and low ejection fraction groups. 
MCA, middle cerebral artery; ACA, anterior cerebral artery; ICA, internal carotid artery; OA, ophthalmic 
artery; VA, vertebral artery; EF, ejection fraction. (* indicates P<0.05).
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Soon afterwards, Korosue et al26 observed a 29% mean 
increase in cardiac output in ischemic stroke patients with 
isovolemic hemodilution associated with increases in regional 
cerebral blood flow.
More recently, Treib et al14 performed a pilot study with 
hypervolemic hemodilution combined with dopamine or 
dobutamine infusion in 24 stroke patients with middle cerebral 
artery occlusions. They measured the influence of blood 
pressure and cardiac output on the TCD PSV in a single 
intracranial vessel, the middle cerebral artery. With therapy 
there was a 53% increase in cardiac output. In the unaffected 
hemisphere, there was a 27% increase in the systolic velocity. 
On the side of the lesion, there was an 11% increase. The 
relative diminished response on the affected side was believed 
to have been due to thrombus burden or counterregulatory 
pathways causing vasoconstriction. Additionally, they 
observed an increase in PI by 46% in the affected and 47% in 
the unaffected hemisphere. This differed from our study since 
we did not observe significant PI differences between the low 
and normal EF groups. A significant difference between our 
studies is that Treib et al’s14 patients received infusions of 
dopamine or dobutamine. 
A translational question of important consideration is 
whether cardiac contractility correlates with functional 
neurological outcome. It is unknown if undifferentiated 
systolic dysfunction promotes expansion of the ischemic 
penumbra, or conversely whether hyperdynamic cardiac 
function enhances the risk of hemorrhagic transformation. 
Although relatively uninvestigated, Korosue et al26 reported 
modest increases in neurological scores with cardiac output 
augmentation. Subsequent isovolemic hemodilution studies 
were not supportive, but to our knowledge they did not record 
cardiac output values.27 No other studies have reported 
improved functional outcome with cardiac augmentation or 
hemodynamic optimization. Additionally, we found no studies 
relating higher cerebral hemorrhage rates to hemodynamic 
augmentation or hyperdynamic states.28,29 
Nevertheless, in the stroke rehabilitation literature, 
Kevorkian et al30 observed better functional recovery in acute 
stroke patients with normal cardiac contractility. Their design 
differed from ours as they stratified acute stroke patients into 
severely depressed (EF<35%) and moderately depressed or 
normal (EF>35%) contractility cohorts. The latter group had 
higher hospital discharge functional scores and higher rates of 
functional status improvement from admission to discharge. 
While the authors conceded their study had several limitations, 
their results suggest that acute stroke patients with preserved 
systolic function may have better functional outcomes than 
those with severe systolic dysfunction. 
Thus, it remains unclear which subgroups of cerebral 
ischemia patients could potentially benefit from cardiac 
output augmentation as suggested by prior authors.31 Beyond 
impaired contractility, it is well-known that subgroups of 
cerebral ischemia patients may have serum troponin elevation 
and arrhythmias — which have been related to higher in-
hospital mortality rates. 21,24,32,33 Currently there is a paucity 
of investigators evaluating the incidence, role, underlying 
mechanisms, and impact of myocardial and hemodynamic 
derangements in the setting of cerebral ischemia. The future 
development of adjunctive evidence-based hemodynamic 
guidelines is critical.
LIMITATIONS
A principle limitation of this study was the retrospective 
design and small sample size. In addition, echocardiograms 
performed by technicians in our institution’s cardiovascular 
lab were susceptible to user variability. Another limitation was 
the heterogeneity of the defined CIE population. While there 
are neurovascular, physiologic and management differences 
between AIS and TIA patients, we postulated that the merging 
of these populations would not significantly impact our results 
for the sake of this preliminary analysis. For example, at our 
institution all AIS and TIA patients have echocardiograms and 
a cerebral vascular study performed prior to discharge. There 
are overlapping co-morbidities between each population, 
including diabetes, hypertension and hyperlipidemia. National 
AIS and TIA guidelines have overlapping recommendations 
for management, and at our institution AIS and TIA patients 
were admitted to the same clinical floors and clinician 
teams.34,35 Thus, given the overlapping characteristics of stroke 
and TIA patients, we thought that the relation between 
cerebral flow velocities and cardiac function would be 
preserved. 
Another limitation of our study was that we did not know 
the prior EF of patients to delineate the underlying mechanism 
for systolic dysfunction. It is possible that patients with 
elevated catecholamine levels from neuro-endocrine activation 
could potentially have myocardial stunning and other 
cerebrovascular perturbations that could alter echocardiogram 
findings and other variables measured in this study. 
A methodological limitation of the retrospective design 
was that TCDs and echocardiograms were performed within 
72 hours of admission, rather than simultaneously. Our study 
was also susceptible to selection bias since many patients 
undergoing TCDs may have had contraindications to magnetic 
resonance imaging or magnetic resonance angiography. 
Another limitation was that the majority of patients in 
our study did not have concomitant cerebral angiography 
performed in order to localize vascular occlusions in the AIS 
patients. Thus, our mean PSV or PI values could have been 
impacted if a patient had a partial or total occlusion of one 
of the large vessels being measured by TCD. For example, 
a patient could have a middle cerebral artery occlusion 
contrasted to a stroke syndrome caused by a more distal 
occlusion in the M1 or M2 portion of the middle cerebral 
artery territory. While our methodology to calculate the mean 
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PSV or PI would help to mitigate this issue, it is a limitation 
that we were unable to control for given the information in the 
medical records and the fact that the majority of these patients 
did not have cerebral angiography performed. 
CONCLUSION
Cerebral blood flow in the internal carotid artery territory 
as measured by the mean PSV in cerebral ischemia patients 
appears to be higher in those with preserved left ventricular 
contractility. Future research is necessary to better understand 
the impact of myocardial contractility on cerebral blood flow 
in patients with acute cerebral ischemia.
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